|
Market Closed -
London S.E.
12:35:18 2026-10-30 EDT
|
5-day change | 1st Jan Change | ||
| 0.1700 GBX | -2.86% |
|
-2.86% | -15.00% |
Company Valuation: Theracryf Plc
Data adjusted to current consolidation scope
| Fiscal Period: March | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
| Market Cap 1 | 12.65 | 12.58 | 3.919 | 6.191 | 5.533 | 6.223 | - |
| Change | - | -0.51% | -68.86% | 57.98% | -10.62% | 12.46% | - |
| Enterprise Value (EV) 1 | 1.317 | 6.354 | 1.358 | 3.34 | 4.91 | 6.154 | 9.243 |
| Change | - | 382.62% | -78.63% | 145.93% | 47.01% | 25.34% | 50.19% |
| P/E | -3.7x | -2.51x | -0.76x | -0.6x | -1.21x | -1.91x | -2.15x |
| PBR | 1.09x | 1.89x | 0.96x | 0.19x | 1.5x | - | - |
| PEG | - | -0.1x | 0x | 0x | 0x | 0x | 0.2x |
| Capitalization / Revenue | - | 22.9x | 7.75x | - | - | - | - |
| EV / Revenue | - | 11.6x | 2.68x | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - |
| EV / EBIT | -0.33x | -1x | -0.3x | -1.16x | -1x | -1.71x | -2.57x |
| EV / FCF | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - |
| EPS 2 | -0.0124 | -0.0182 | -0.0146 | -0.00488 | -0.00212 | -0.00119 | -0.00106 |
| Distribution rate | - | - | - | - | - | - | - |
| Net sales 1 | - | 0.5487 | 0.5059 | - | - | - | - |
| EBITDA | -3.996 | -6.32 | -4.54 | -2.574 | -4.535 | - | - |
| EBIT 1 | -4.016 | -6.336 | -4.555 | -2.878 | -4.892 | -3.6 | -3.6 |
| Net income 1 | -3.433 | -5.019 | -4.007 | -2.63 | -4.675 | -2.955 | -2.955 |
| Net Debt 1 | -11.33 | -6.229 | -2.561 | -2.851 | -0.6236 | -0.0689 | 3.02 |
| Reference price 2 | 0.046008 | 0.045774 | 0.011061 | 0.002907 | 0.002575 | 0.002277 | 0.002277 |
| Nbr of stocks (in thousands) | 274,888 | 274,888 | 354,288 | 2,129,622 | 2,148,964 | 2,732,297 | - |
| Announcement Date | 6/8/22 | 6/7/23 | 5/28/24 | 6/3/25 | 9/28/26 | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.91x | - | - | - | 6.22M | ||
| 16.87x | 6.34x | 12.15x | 1.77% | 63.77B | ||
| 30.14x | 8.25x | 27.02x | 0.04% | 56.37B | ||
| 37.48x | 6.65x | 19.86x | 0.86% | 54.62B | ||
| 34.85x | 3.31x | 14.29x | -.--% | 44.06B | ||
| 48.85x | 5.63x | 30.81x | -.--% | 42.11B | ||
| -19.86x | 192.36x | -21.16x | -.--% | 41B | ||
| 47.33x | 8.41x | 28.18x | -.--% | 34.92B | ||
| 32x | 8.13x | 21.15x | 0.41% | 32.82B | ||
| -71.62x | 13.03x | -68.47x | -.--% | 24.7B | ||
| Average | 15.41x | 28.01x | 7.09x | 0.34% | 39.43B | |
| Weighted average by Cap. | 21.64x | 26.34x | 11.23x | 0.45% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- EVG Stock
- Valuation Theracryf Plc
Select your edition
All financial news and data tailored to specific country editions
















